Study of Sacituzumab Govitecan in Patients With Solid Tumor

NCT05119907 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Sacituzumab Govitecan-hziy

Sponsor

Gilead Sciences